Evidence map›Paper›PMID 26064416›Full record

ReviewOxidative medicine and cellular longevity2015

Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.

Dongdong Wu, Jun Wang, Hui Li, Mengzhou Xue, Ailing Ji, Yanzhang Li

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Exogenous HOpen medicine (Warsaw, Poland) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. HMolecular neurobiology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. AP39, a Mitochondrial-Targeted HJournal of clinical medicine · 2022
    Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dongdong WuMedical College of Henan University, Kaifeng, Henan 475004, China.
Jun WangMedical College of Henan University, Kaifeng, Henan 475004, China.
Hui LiMedical College of Henan University, Kaifeng, Henan 475004, China.
Mengzhou XueDepartment of Neurology, Institute of Neurological Disorders, The First Affiliated Hospital of Henan University, Kaifeng 475001, China.
Ailing JiMedical College of Henan University, Kaifeng, Henan 475004, China.
Yanzhang LiMedical College of Henan University, Kaifeng, Henan 475004, China.
Henan University · CNFirst Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion (I/R) injury is one of the major causes of high morbidity, disability, and mortality in the world. I/R injury remains a complicated and unresolved situation in clinical practice, especially in the field of solid organ transplantation. Hydrogen sulfide (H2S) is the third gaseous signaling molecule and plays a broad range of physiological and pathophysiological roles in mammals. H2S could protect against I/R injury in many organs and tissues, such as heart, liver, kidney, brain, intestine, stomach, hind-limb, lung, and retina. The goal of this review is to highlight recent findings regarding the role of H2S in I/R injury. In this review, we present the production and metabolism of H2S and further discuss the effect and mechanism of H2S in I/R injury.

Indexed as

AnimalsHumansHydrogen SulfideMyocardial Reperfusion InjuryOrgan SpecificityHydrogen Sulfide

Identifiers

PMID26064416
PMCPMC4443900
OpenAlexW1533335987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.